A Study to Test How Well Men Tolerate Different Doses of BI 3006337
Clinical trial NCT05076422 · COMPLETED
Trial details
- NCT number
- NCT05076422
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-18
- Primary completion
- 2023-03-03
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.